BASF boosts API, excipient prices; Pfizer sells Capsugel to investor;

> BASF has increased the price of its APIs and drug excipients by 10 percent. Story

> Pfizer is selling its capsule-making unit, Capsugel, for $2.375 billion in cash to investment firm Kohlberg Kravis Roberts & Co.  Release

> India has approved a life sentence for anyone convicted of making fake drugs and distributing them in Nigeria. Item

> The Process Analytical Technology initiative will drive demand for instrumentation, says Frost and Sullivan. Story

> China's drug regulator, focused on improving drug safety, quality, and effectiveness, is turning to FDA regulations as a guide. Blog

> A top 10 drugmaker has selected Payne Security holographic tear tape for counterfeit protection and tamper evidence. Article

> For the second time in six years, Mylan Pharmaceuticals is expanding its distribution center in southeast Greensboro, NC, adding 162,400 square feet of space. News

> Supply chain service provider Tracelink says that half of Catalent Pharma Solutions' U.S. manufacturing sites have been added to its network. Report

> The consultancy Life Science Link has signed a deal with QuaDPharma for small scale pharmaceutical manufacturing services at Niagara Medical Campus in New York. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.